[{"id":5890,"regimens":[{"id":11006,"duration":{"id":5064,"approximate_duration":"on-going","dates_unknown":true},"drug":{"id":11227,"name":"Tenofovir Alafenamide","url":"cure-api2.ncats.io/v1/drugs/11227","rxNorm_id":null,"notes":null},"use_drug":[{"id":7314,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11006},{"id":7315,"answer":"In a novel combination with another drug","answer_other":"","regimen":11006}],"created":"2020-09-13T22:57:43.459174Z","updated":"2020-09-13T23:13:38.887426Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":5890},{"id":11007,"duration":{"id":5065,"approximate_duration":"on-going","dates_unknown":true},"drug":{"id":7601,"name":"Emtricitabine","url":"cure-api2.ncats.io/v1/drugs/7601","rxNorm_id":null,"notes":null},"use_drug":[{"id":7316,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11007},{"id":7317,"answer":"In a novel combination with another drug","answer_other":"","regimen":11007}],"created":"2020-09-13T22:57:43.466621Z","updated":"2020-09-13T23:13:38.893974Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":5890},{"id":11008,"duration":{"id":5066,"approximate_duration":"on-going","dates_unknown":true},"drug":{"id":7166,"name":"Darunavir-Cobicistat","url":"cure-api2.ncats.io/v1/drugs/7166","rxNorm_id":null,"notes":null},"use_drug":[{"id":7318,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11008},{"id":7319,"answer":"In a novel combination with another drug","answer_other":"","regimen":11008}],"created":"2020-09-13T22:57:43.472864Z","updated":"2020-09-13T23:13:38.899887Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":5890},{"id":11009,"duration":{"id":5069,"approximate_duration":"4 days","dates_unknown":true},"drug":{"id":8467,"name":"Interferon Beta-1B","url":"cure-api2.ncats.io/v1/drugs/8467","rxNorm_id":null,"notes":null},"use_drug":[{"id":7320,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11009},{"id":7321,"answer":"In a novel combination with another drug","answer_other":"","regimen":11009}],"created":"2020-09-13T22:57:43.479037Z","updated":"2020-09-13T23:13:38.945191Z","dose":"250 μg (8 million units)","frequency":"Every 48 hours","route":"","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":5890},{"id":11010,"duration":{"id":5068,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7066,"name":"Corticosteroids","url":"cure-api2.ncats.io/v1/drugs/7066","rxNorm_id":null,"notes":null},"use_drug":[{"id":7322,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11010},{"id":7323,"answer":"In a novel combination with another drug","answer_other":"","regimen":11010}],"created":"2020-09-13T22:57:43.485073Z","updated":"2020-09-13T23:13:38.912200Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":5890},{"id":11011,"duration":{"id":5070,"approximate_duration":"5 days","dates_unknown":true},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":7324,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11011},{"id":7325,"answer":"In a novel combination with another drug","answer_other":"","regimen":11011}],"created":"2020-09-13T23:13:38.940553Z","updated":"2020-09-13T23:13:38.946132Z","dose":"400 mg twice a day with a loading dose on the first day and then 200 mg twice a day for 4 days","frequency":"BD","route":"","severity":null,"severity_detail":null,"comments":null,"report":5890}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":7705,"answer":"Clinical assessment","answer_other":"","report":5890}],"how_diagnosis":[{"id":13105,"answer":"Clinical assessment","answer_other":"","report":5890},{"id":13106,"answer":"Imaging","answer_other":"","report":5890},{"id":13107,"answer":"PCR","answer_other":"","report":5890}],"author_username":"Reema Charles","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":3821,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":5890}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[{"id":193,"answer":"White","answer_other":""}],"created":"2020-09-13T22:45:49.507533Z","updated":"2020-09-13T23:13:38.879563Z","title":"COVID-19 in patients with HIV: clinical case series. Case 5","status":"Approved","anonymous":false,"published":true,"pubmed_id":32304642,"doi":"10.1016/S2352-3018(20)30111-9","article_url":"https://pubmed.ncbi.nlm.nih.gov/32304642/","pub_year":2020,"published_authors":"Blanco JL\r\nAmbrosioni J\r\nGarcia F\r\nMartínez E\r\nSoriano A\r\nMallolas J\r\nMiro JM\r\nCOVID-19 in HIV Investigators.","article_author_email":"Author email could not be found.","journal":"The lancet. HIV","abstract":"On March 9, 2020, 2 weeks into the COVID-19 outbreak in Spain, 543 consecutive patients with SARS-CoV-2 infection had been admitted to hospital at Hospital Clínic Barcelona, Barcelona, Spain. We admitted 62 (12%) into intensive care units and we discharged 208 (38%) with supervised outpatient care. Of all patients, five (0·92%; 95% 0·39–2·14) were HIV positive, of whom three were male and two were transgender, and four identified as men who have sex with men (MSM). Two patients had comorbid conditions.","article_type":"Original","study_type":"Case Report","number_of_patients":5,"article_patient_number":"5","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"31-40 years","sex":"Other","ethnicity":"Hispanic/Latino","country_contracted":"Spain","country_treated":"Spain","began_treatment_year":"2020","hiv":true,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Respiratory tract infection","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"Transgender\r\nMSM, sexual worker\r\nNo ART: current diagnosis is late presenter - diagnosed in 2020\r\nSpO2 <90%\r\nRight basal pneumonia with pleural effusion\r\nNon-invasive ventilation\r\nConcomitant Pneumocystis jiroveci and bacterial pneumonia treatment, Azithromycin (for 5 days), ceftaroline fosamil (for 7 days), co-trimoxazole (for 21 days, followed by secondary prophylaxis)","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[7066,7166,7601,8342,8467,11227]},{"id":5929,"regimens":[{"id":11091,"duration":{"id":5150,"approximate_duration":"5 days","dates_unknown":true},"drug":{"id":8783,"name":"Lopinavir-Ritonavir","url":"cure-api2.ncats.io/v1/drugs/8783","rxNorm_id":null,"notes":null},"use_drug":[{"id":7442,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11091},{"id":7443,"answer":"In a novel combination with another drug","answer_other":"","regimen":11091}],"created":"2020-09-16T03:32:18.562806Z","updated":"2020-09-16T03:49:40.004771Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":5929},{"id":11092,"duration":{"id":5151,"approximate_duration":"5 days","dates_unknown":true},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":7444,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11092},{"id":7445,"answer":"In a novel combination with another drug","answer_other":"","regimen":11092}],"created":"2020-09-16T03:32:18.570290Z","updated":"2020-09-16T03:49:40.011625Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":5929},{"id":11093,"duration":{"id":5152,"approximate_duration":"5 days","dates_unknown":true},"drug":{"id":11227,"name":"Tenofovir Alafenamide","url":"cure-api2.ncats.io/v1/drugs/11227","rxNorm_id":null,"notes":null},"use_drug":[{"id":7446,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11093},{"id":7447,"answer":"In a novel combination with another drug","answer_other":"","regimen":11093}],"created":"2020-09-16T03:32:18.576526Z","updated":"2020-09-16T03:49:40.017357Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":5929},{"id":11094,"duration":{"id":5153,"approximate_duration":"5 days","dates_unknown":true},"drug":{"id":7601,"name":"Emtricitabine","url":"cure-api2.ncats.io/v1/drugs/7601","rxNorm_id":null,"notes":null},"use_drug":[{"id":7448,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11094},{"id":7449,"answer":"In a novel combination with another drug","answer_other":"","regimen":11094}],"created":"2020-09-16T03:32:18.582582Z","updated":"2020-09-16T03:49:40.023695Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":5929}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":7757,"answer":"Clinical assessment","answer_other":"","report":5929}],"how_diagnosis":[{"id":13211,"answer":"Clinical assessment","answer_other":"","report":5929},{"id":13212,"answer":"Imaging","answer_other":"","report":5929},{"id":13213,"answer":"PCR","answer_other":"","report":5929}],"author_username":"Reema Charles","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":3870,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":5929}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[{"id":224,"answer":"White","answer_other":""}],"created":"2020-09-16T03:28:41.282626Z","updated":"2020-09-16T03:49:39.996599Z","title":"Darunavir does not prevent SARS-CoV-2 infection in HIV patients. Case 2","status":"Approved","anonymous":false,"published":true,"pubmed_id":32325127,"doi":"10.1016/j.phrs.2020.104826","article_url":"https://pubmed.ncbi.nlm.nih.gov/32325127/","pub_year":2020,"published_authors":"Riva A\r\nConti F\r\nBernacchia D\r\nPezzati L\r\nSollima S\r\nMerli S\r\nSiano M\r\nLupo A\r\nRusconi S\r\nCattaneo D\r\nGervasoni C","article_author_email":"Author email could not be found.","journal":"Pharmacological research","abstract":"63-years old HIV-infected man on darunavir-based antiretroviral therapy (given at 800 mg coformulated with cobicistat, tenofovir alafenamide and emtricitabine); at the last outpatient visit he had an undetectable viral load (<20 copies/mL) and a CD4+ count of 0.743 × 10^3/μL. He was also on active treatment with irbesartan for arterial hypertension. On March 18 the patient was admitted to the emergency department reporting fever up to 38.0 °C for at least 11 days with no signs of respiratory distress; he also reported that some members of his family living near Bergamo were tested positive for SARS-Co-V-2 infection.","article_type":"Original","study_type":"Case Report","number_of_patients":3,"article_patient_number":"2","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"61-70 years","sex":"Male","ethnicity":"Not Hispanic/Latino","country_contracted":"Italy","country_treated":"Italy","began_treatment_year":"2020","hiv":true,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":true,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"active treatment with irbesartan for arterial hypertension","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Respiratory tract infection","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"The chest x-ray evidenced a bilateral reticular interstitial thickening and the nasopharyngeal swab for SARS-CoV-2 resulted positive. At hospital admission darunavir/cobicistat was replaced with lopinavir/ritonavir (plus tenofovir alafenamide plus emtricitabine) and hydroxychloroquine given for 5 days. On March 28 he was successfully discharged.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[7601,8342,8783,11227]}]